Generic competition
WHO releases document detailing stakeholder implementation of Global Strategy: Public health, innovation and IP
Submitted by thiru on 18. May 2009 - 2:47On Monday, 18 May 2009, WHO released document A62/16 Add.3 entitled “Open paragraphs on stakeholders“.
The link for this document is: http://apps.who.int/gb/ebwha/pdf_files/A62/A62_16Add3-en.pdf
The cover sheet of this document states:
Submissions of Member States and Stakeholders to WHO Expert Working Group on R&D Financing
Submitted by thiru on 11. May 2009 - 7:22The contributions from WHO Member States and other Stakeholders to the Expert Working Group on R&D financing are now available on the WHO website.
The following extract is taken from the WHO public hearing website:
KEI comments to WHO EWG
Submitted by James Love on 16. April 2009 - 10:32KEI filed comments with the WHO Expert Working Group. A copy is available here.
EC’s two medicines in transit exceptions
Submitted by James Love on 24. March 2009 - 6:00At the WIPO SCP coffee break, one attendee explained to KEI that the EU has in two places, (1) the regulations on tiered pricing, and (2) the implementation of the WTO’s 30 August 2003 decision on compulsory licensing, created an exception for goods in transit to developing countries.
DG Trade and DG Customs Union reply to TACD on Seizures of Medicines in Transit
Submitted by James Love on 24. March 2009 - 3:47The European Commissioners for External Trade and for Taxation and Customs Union have replied to TACD in a letter available here:
Dear All,
Notes from Day one of WIPO SCP 13
Submitted by James Love on 24. March 2009 - 1:50WIPO’s five day 13th meeting of the Standing Committee on the Law of Patents (SCP) began on Monday, and will go through Friday. The agenda is quite full, as the SCP will consider four important reports written by the Secretariat.
SCP/13/2: Standards and Patents
SCP/13/3: Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP/13/4: The Client-Attorney Privilege
SCP/13/5: Dissemination of Patent Information
WHO issues mild statement on transit of medicines
Submitted by James Love on 13. March 2009 - 7:24The WHO has just issued a statement on the transit of medicines. It is short and mild. The statement does not mention goods in transit in the title. It does not mention at all that medicines have been seized. The best part of the statement is the following quote:
Ensuring that the interests of trade and health are appropriately managed, also means that the flow of legitimate medicines, including generic medicines, is not impeded.
The action part of the statement is weak, however:
NGO views: World Health Organization (WHO) voice on issue of medicines in transit to developing countries?
Submitted by thiru on 13. March 2009 - 3:51On 18 February 2009, 16 civil society groups sent a letter to Director-General Dr. Chan on the matter of the Dutch seizures of generic medicines in-transit to developing countries. In the letter, Dr.
PhRMA Special 301 submission on Thailand
Submitted by James Love on 12. March 2009 - 16:11The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:
PhRMA’s Aggressive Special 301 submission for the Philippines
Submitted by James Love on 12. March 2009 - 7:01One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR.
